The heart rate, quantity and quality of cardiac arrhythmias and ST segment evaluation after administration of 100 μg of carbetocin intravenously or 5 IU of intravenous oxytocin did not show any differences; therefore there is no indication for the use of a specific drug in the doses discussed. The gene discussed is OXT; the disease is cardiac rhythm disease.